1. Home
  2. VKTX vs PI Comparison

VKTX vs PI Comparison

Compare VKTX & PI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VKTX
  • PI
  • Stock Information
  • Founded
  • VKTX 2012
  • PI 2000
  • Country
  • VKTX United States
  • PI United States
  • Employees
  • VKTX N/A
  • PI N/A
  • Industry
  • VKTX Biotechnology: Pharmaceutical Preparations
  • PI Industrial Machinery/Components
  • Sector
  • VKTX Health Care
  • PI Technology
  • Exchange
  • VKTX Nasdaq
  • PI Nasdaq
  • Market Cap
  • VKTX 3.4B
  • PI 3.0B
  • IPO Year
  • VKTX 2015
  • PI 2016
  • Fundamental
  • Price
  • VKTX $34.07
  • PI $96.75
  • Analyst Decision
  • VKTX Strong Buy
  • PI Strong Buy
  • Analyst Count
  • VKTX 14
  • PI 9
  • Target Price
  • VKTX $97.29
  • PI $172.22
  • AVG Volume (30 Days)
  • VKTX 4.8M
  • PI 818.9K
  • Earning Date
  • VKTX 02-05-2025
  • PI 02-05-2025
  • Dividend Yield
  • VKTX N/A
  • PI N/A
  • EPS Growth
  • VKTX N/A
  • PI N/A
  • EPS
  • VKTX N/A
  • PI 1.39
  • Revenue
  • VKTX N/A
  • PI $366,087,000.00
  • Revenue This Year
  • VKTX N/A
  • PI $24.39
  • Revenue Next Year
  • VKTX $986.87
  • PI $22.64
  • P/E Ratio
  • VKTX N/A
  • PI $69.60
  • Revenue Growth
  • VKTX N/A
  • PI 19.04
  • 52 Week Low
  • VKTX $28.64
  • PI $96.69
  • 52 Week High
  • VKTX $99.41
  • PI $239.88
  • Technical
  • Relative Strength Index (RSI)
  • VKTX 51.41
  • PI 21.83
  • Support Level
  • VKTX $28.90
  • PI $101.71
  • Resistance Level
  • VKTX $34.37
  • PI $108.68
  • Average True Range (ATR)
  • VKTX 2.37
  • PI 5.21
  • MACD
  • VKTX 0.66
  • PI -0.41
  • Stochastic Oscillator
  • VKTX 70.06
  • PI 0.18

About VKTX Viking Therapeutics Inc.

Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.

About PI Impinj Inc.

Impinj Inc operates a platform that enables wireless connectivity to everyday items by delivering each item's identity, location, and authenticity to business and consumer applications. Its platform includes endpoint integrated circuits (ICs) product, a miniature radios-on-a-chip, which attach to and identify their host items; and connectivity layer that comprises readers, gateways, and reader ICs to wirelessly identify, locate, authenticate, and engage endpoints via RAIN, as well as provide power to and communicate bidirectionally with endpoint ICs. Geographically, the company has a business presence in the Americas, Asia Pacific, Europe, Middle East and Africa, of which key revenue is derived from the operations in the Asia Pacific region.

Share on Social Networks: